According to a new report published by K D Market Insights, titled, “Wearable injectors Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global wearable injectors market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032.  The increasing prevalence of chronic diseases and the need for convenient and efficient drug delivery systems. Additionally, advancements in wearable technology and the growing trend of self-administration of medications which are the major factors augmenting the growth of the global wearable injectors market.

The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and autoimmune disorders, fuels the demand for wearable injectors. These devices offer benefits such as precise and controlled drug delivery, reducing the burden of frequent injections and improving patient compliance are further expected to create ample growth opportunities for the global wearable injectors market during the forecast period i.e., 2023-2032. Moreover, the need for patient-centric care and the growing trend of self-administration of medications has propelled market expansion. Advancements in wearable technology and the integration of smart features in wearable injectors, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global wearable injectors market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the presence of well-established healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies.

According to type, the on-body injectors segment accounted for the largest market share in the wearable injectors market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global wearable injectors market is segmented into type, technology, therapy, end user and region. Based on type, the market is bifurcated into on-body, off-body. Based on technology, it is classified into spring-based, motor- based, rotary pump, expanding battery, other. Based on therapy, it is classified into immuno-oncology, diabetes, cardiovascular disease, other disease. Based on end user, it is classified into hospitals, homecare settings, other healthcare facilities.

The global wearable injectors market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Wearable injectors Market

• On the basis of type, the on-body injectors segment accounted for the largest market share in the wearable injectors market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
• On the basis of region, North America accounted for the largest share in the global wearable injectors market in 2022. The region is further projected to continue dominating in the market during the forecast period.
• On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.

Some of the major wearable injectors companies profiled in the report include Ypsomed, Amgen, Subcuject, Enable Injections, Medtronic plc, Insulet Corporation, United Therapeutics Corp., CeQur SA, Sensile Medical, ATS Automation, West Pharmaceutical Services, Inc., Tandem Diabetes Care, Valeritas, Sonceboz, Noble, Elcam Drug Delivery Devices, Bespak Europe Ltd., Stevanato Group, Sorrel Medical, Weibel CDS AG.

Related Reports :-

https://www.kdmarketinsights.com/reports/smart-pill-boxes-bottles-market/5394

https://www.kdmarketinsights.com/reports/endoscopic-ultrasound-needles-market/5393

https://www.kdmarketinsights.com/reports/brain-monitoring-market/5392

https://www.kdmarketinsights.com/reports/collagen-wound-dressing-market/5391